Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a Locations section showing the Philadelphia, PA site (Abramson Cancer Center of the University of Pennsylvania) and updated the page revision to v3.3.3; removed the older Pennsylvania Locations entry and the HHS Vulnerability Disclosure link (v3.3.2).
    Difference
    0.3%
    Check dated 2025-12-23T21:04:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    - The page revision updated from v3.2.0 to v3.3.2. No study content or data appears to be changed.
    Difference
    0.1%
    Check dated 2025-11-25T10:23:35.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The funding-status banner at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T06:47:52.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    No additions or deletions to core Study Details content were detected for NCT02041260. The page’s primary information, including eligibility criteria and trial details, remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T20:38:42.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:50.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:59.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.